Abstract
| INTRODUCTION
Rheumatoid arthritis (RA) occurs in the synovial joints, where synovitis can lead to dysfunction of cartilage and bone, ultimately causing the deterioration of joint function. 1 Persistent inflammatory response is found in the synovial tissue of RA patients, which characterized by infiltration of monocytes and granulocytes, along with pathologic T and B cells. 2, 3 In view of the complex aetiologies, limiting the inflammation with the disease-modifying anti-rheumatic drug to slow down disease progression was extensively used in the clinic. 1 However, for some of nonresponders, new therapy is needed for achieving disease modifying.
Acacetin, an O-methylated flavone, exacted from Saussurea involucrata plant, possessed the anti-tumour and antiinflammatory properties. 4, 5 Mounting studies reported that acacetin repressed the damages induced by endotoxin and ischaemia/reperfusion that related to the sthenic reactive oxygen production-innate arm of immune response. [6] [7] [8] Here, we tried to discuss the possibility that acacetin regulated the adaptive immune response to control innate arm of immunity, then altering the disease progression. CD4+ T helper cells engaged in the development of autoimmune diseases. 9 Previously, disordered balance of interleukin-17-producing T helper (Th17) cells and regulatory T (Treg) cells was empathized in the exacerbation of RA. 10 Excessive IL-17 in knee-joint drove the generation of osteoclasts, whereas Treg cells inhibited the function of Th17 cells and slowed down the progression of autoimmune arthritis. 11, 12 However, an elegant study reported that most pathological Th17 cells originated from antigenexperienced Treg cells under the arthritic conditions. 13 This observation indicated an inseparable relationship between Th17 and Treg cells in both origin and effector arms. More recently, evidence highlighted that transcriptional coactivator TAZ engaged in the reciprocal differentiation of Th17/ Treg through regulating acetylation of Foxp3. 14 Given that acacetin has been reported to inhibit the inflammatory signalling in the fibroblast-like synoviocytes, systemic delivery of acacetin might impact the outcome of Th17 and Treg cellular responses in vivo. 15 Here we hypothesized that acacetin might impact the outcome of collagen-induced arthritis (CIA) partly through regulating Th17/Treg differentiation.
| MATERIALS AND METHODS

| Animals
Male DBA/1J mice were obtained from the Beijing Vital River Laboratory Animal Technology Co., Ltd and housed in the Animal Center of Xuzhou Medical University. The animal experimental procedures were approved by Ethical Committee of Xuzhou Medical University.
| Animal experiment
The induction of CIA was performed on the DBA/1J mice with a dose of 100 μg bovine type II collagen (CII) plus 100 μL completed Freund's adjuvant (FA, Sigma-Aldrich, St. Louis, MO, USA) at week 0, followed by a dose of 100 μg CII plus 100 μL incompleted FA at week 3. Acacetin (Purity: 99%, Nanjing Finetech Chemical Co., Ltd; CAS 480-44-4) was first dissolved in DMSO and then diluted by saline for administration. Mice were i.v. injected with 5 mg/kg or 20 mg/kg Acacetin once a week. The changes of arthritis incidence and clinic scores were calculated every week to trace the progression of CIA. The clinic scores were performed as: 0 = no change; 1 = paw with mild swelling at single limb; 2 = more than one paw with swelling; 3 = all paw with swelling and obvious erythema; and 4 = whole paw with severe swelling (The highest score is 16).
| Histology
After sacrificed, the paws of mice were collected, fixed, and decalcified with EDTA. Sections from paraffinembedded tissue were stained with haematoxylin and eosin or Safranin O. The inflammation and cartilage scores were perform with previous reports. 16 
| Generation of bone morrow-derived dendritic cells
Bone morrow cells were isolated from femur of hind leg. Then the cells were cultured in the RPMI 1640 medium supplement with 10% FBS (Gibico), 2 mmol/L L-glutamine, 0.1 mmol/L 2-mercaptoethanol, 2 mmol/L nonessential amino acid (all from Sigma-Aldrich) for 7 days in the presence of 20 ng/mL GM-CSF (Proteintech, NJ, USA). Then immature DCs were re-plated and stimulated with 10 ng/mL TNF-α (Proteintech) in the presence of 0, 100, and 500 μmol/L acacetin for 2 days. The culture supernatant was collected for ELISA assays.
| Mouse Th17 cell differentiation
The CD4+ T cells from spleen were purified by a CD4-negative magnetic cell separation (Miltenyi Biotec, Auburn, CA, USA). Cells were plated in the 96-well plates which precoated with anti-CD3 and anti-CD28 purified antibodies (Proteintech) for 12 hours in RPMI 1640 medium supplement with 10% FBS, 2 mmol/L L-glutamine, 0.1 mmol/L 2-mercaptoethanol, 2 mmol/L nonessential amino acid. Then 30 ng/mL IL-6 and 2.5 ng/mL TGF-β1 (Proteintech) were added into the culture for Th17 cell differentiation. Three days later, the cells were harvested for intracellular cytokine/Foxp3 staining.
| Cytokine and antibodies measurement
Cytokine assays were performed with the IFN-γ, IL-17, IL-6, IL-18, IL-10, TGF-β1, and MCP-1 ELISA kits (R&D systems, MN, USA) in the guideline of manufacturer's F I G U R E 1 Treatment of acacetin repressed the development of collagen-induced arthritis in vivo. Six-week-old male DBA/1J mice were used to perform CIA induction. 100 μL complete/incomplete Freund's Adjuvants emulsified with 100 μg CII were subcutaneous injected into the skin around the tail at day 0 or day 21. Mice were administered i.v. with acacetin or vehicle once per week until sacrifice (started at day −1). The alteration of arthritis incidence (A) and clinic scores (B) was measured every week to view progression of CIA. Mice were sacrificed at week 9 and the histological changes were evaluated. C, The typical H&E and Safranin O images. Quantization of inflammation (D) and cartilage damage (E). Levels of serum total IgG (F) and IgG1 (G) were measured at week 9. Levels of serum CII-specific IgG (I), IgG1 (J), and IgG2a (K). n = 6-8 per group. Data were pooled from two individual experiments and shown as box + whiskers and Min to Max. Middle bar represented median. *P < 0.05, **P < 0.01, ***P < 0.001 introductions. The serum antibody determinations were performed with Mouse IgG and IgG1 ELISA kits (Cayman Chemical, Ann Arbor, Michigan, USA) in the guideline of manufacturer's introductions. The CII-specific IgG, IgG1, and IgG2a antibodies were detected by indirect ELISA. Briefly, 1 μg per well of CII was precoated in a 96-well ELISA plate overnight. After washed and blocked by PBS/5% Tween 20/ 3% BSA, 100 μL per well of diluting serum (1:500) was added and incubated at 37°C for 1 hour. After washed, horseradish peroxidase-labelled goat-anti mouse IgG or IgG1 (Santa Cruz Biotechnology, Santa Cruz, CA, USA) were added and incubated at 37°C for 1 hour. After washed for five times, 100 μL per well tetramethylbenzidine was incubated in plate at room temperature and 10% H 2 SO 4 was used for stop chromogenic reaction. The OD values were detected by a Microplate Reader (Bio-Rad, Hercules, CA, USA).
| Flow cytometry assays
For Th1 and Th17 cell assays, the cells were activated by Cell Activation Cocktail (Biolegend, San Diego, CA, USA) for 4 hours, stained with PE-conjugated anti-CD4 antibody (clone GK1.5), and then fixed/permeabilized with Intracellular Fixation & Permeabilization Buffer Set (Biolegend) with APC-conjugated anti-IFN-γ (clone XMG1.2) and anti-IL-17A antibodies (clone TC11-18H10.1, Biolegend). For Treg cell assay, the cells were first stained with FITC-conjugated anti-CD25 (clone PC61.5) and PE-conjugated anti-CD4, and then fixed/permeabilized with the Foxp3 Staining Buffer Set (eBioscience) with APC-conjugated anti-Foxp3 (clone FJK-16S, eBioscience). For PI staining, the cells were stained with PI for 5 minutes in dark and analysed immediately. The cells were analysed by a BD Calibur flow cytometer and data were processed by FLOWJO software.
| Cell proliferation detection
The cells were simulated with anti-CD3 and anti-CD28 antibodies for 3 days and then the cell proliferation was analysed by CCK-8 kits according to the introduction of manufacturer.
| Real-time polymerase chain reaction
The RNA was exacted by a TRzol reagent and cDNA was synthesized by reverse transcription. Q-PCR was performed with the primers that listed as followed: IL-17A-Forward; TTTAACTCCCTTGGCGCAAAA, IL-17A-Reverse; CTTT CCCTCCGCATTGACAC, TAZ-Forward; GAGCAACAT GGACGAGATGG, TAZ-Reverse; AGGTTAGAAAGGG CTCGCTT, IL-10-Forward; TTTGAATTCCCTGGGTGA GAA, IL-10-Reverse; GGAGAAATCGATGACAGCGC.
| Western blot analysis
The cells were lysed by RIPA solution and the quantitative protein detection was performed with a BCA kit. 30 μg total protein was loaded and target protein was separated by a 10% polyacrylamide gel. After electrictransferred, the membrane was blocked by 5% skim milk and incubated with rabbit anti-mouse TAZ antibody (Abcam) for 12 hours. The horseradish peroxidase-conjugated goat anti-rabbit antibody were used for incubation. The band in the membrane was detected with an ECL detection kit.
| Statistical analysis
The statistical analysis of data was performed with GRAPH-PAD PRISM7.0 software. Kruskal-Wallis tests were used for multiple comparisons and Mann-Whitney tests were used for comparison between two groups. P values less than 0.05 was considered statistically significant.
| RESULTS
| Intravenous administration of acacetin repressed the development of collagen-induced arthritis in mice
To clarify the effect of acacetin in the development of CIA, DBA/1J mice were administrated with Freund's adjuvant+ bovine type II collagen (CII) at week 0 and week 3 to induce CIA. The 5 mg/kg or 20 mg/kg of acacetin were intravenously injected once a week after the initiation of CIA for six weeks (Figure 1 ). An individual group of mice that received saline was served as control. The alterations of clinic symptoms and the incidence of CIA were traced in 1 week interval. All mice were sacrificed at week 9 to measure the histology. We found that administration of mice with acacetin significantly reduced the incidence of CIA and the pathological swelling of limbs ( Figure 1A-B) . The histological assays suggested a reduction of inflammation and cartilage damage in the recipients of acacetin, which was associated with the dose used ( Figure 1C-E) . Next, the total antibody and CII-specific antibody productions were detected by ELISA. Both 5 and 20 mg/kg of acacetin significantly inhibited the increase of serum total antibodies and CII-specific antibodies upon the CIA induction ( Figure 1F-K) . These results demonstrated that acacetin repressed the incidence and the progression of autoimmune arthritis and inhibited the antibody productions in the CIA mice.
| Dampening Th17 response and augmented Treg response were observed in the recipients of acacetin
To investigate the alterations of the Th17 and Treg immune responses after the acacetin treatment, the lymphocytes were isolated from spleen at week 9. Treg cells, Th1 cells, and Th17 cells were analysed by intracellular transcription factor/cytokine staining using the following antibodies: CD4, Foxp3, IFN-γ, and IL-17. The results indicated that administration of mice with 20 mg/kg acacetin showed a potent influence on the percentages of Treg cells, Th1 cells, and Th17 cells. Increased Treg cells and reduced Th1/Th17 cells were found (Figure 2A-D) . Moreover, the CII-specific cytokines were detected in the supernatant of splenocytes after ex vivo restimulation with CII. The lymphocytes from the recipients of 20 mg/kg acacetin produced less IFN-γ and IL-17, but more IL-10 than lymphocytes from the vehicle group ( Figure 2E) .
Next, to explore the effects of acacetin on the early stage of CIA development, we measured the ratio of Treg cells and Th17 cells in the inguinal lymph nodes at day 10 post the primary immunization. These mice experienced the acacetin treatment at day −1 and day 6. The results showed that Treg cells were significantly augmented in the recipients of 20 mg/kg acacetin; in contrast, the Th17 cells were significantly decreased ( Figure 3A-C) , implicating a conversion of Treg and Th17 immune response. These data indicated that systemic delivery of acacetin could impact the balance of Treg/Th17 response.
| Acacetin regulated the balance of Th17/ Treg in vitro
The influence of acacetin on the development of adaptive immune response might be multiple. Here, we surmised that acacetin might directly impact the differentiation of Th17 and Treg cells. Total CD4+ T cells were purified from spleen of naïve DBA/1J mice and cultured under the Th17-polarized condition with 100, 200, or 500 μmol/
F I G U R E 3 The alterations of Treg and
Th17 immune responses after the initial immunization. The mice were immunized with 100 μL complete Freund's Adjuvants emulsified with 100 μg CII at day 0. Acacetin was i.v. injected at day −1 and day 6. The lymphocytes isolated from inguinal lymph nodes were performed with Foxp3 staining directly or seeded in a 48-well plate in the presence of Cell Activation Cocktail (containing BFA) for 4 h to measure the ratios of IFN-γ-or IL-17-producing CD4+ T cells. The percentages of Treg (A) and Th17 (B) cells were calculated. The typical images of Tregs and Th17 cell FACS analysis are shown in (C). n = 6-8 per group. Data were pooled from two individual experiments and shown as box + whiskers and Min to Max. Middle bar represented median. **P < 0.01, ***P < 0.001 L acacetin. The ratio of Th17 differentiation was measured after the stimulation of Cell Activation cocktail. Given that the stimulation of cell activation cocktail resulted in loss of Foxp3 expression, cells were divided to duplicate for the detection of IL-17A or CD25 plus Foxp3 respectively. The results showed that with the increasing concentrations of acacetin, the percentage of Th17 cells were decreased, whereas Treg cells were expanded ( Figure 4A-C) . In addition, IL-17 and IL-10 levels in the supernatant of culture also proved that acacetin could limit the production of IL-17A and sustained Treg functions (Figure 4D-E) . Next, we tried to test the effect of acacetin on the antigen-presenting cells which impacted T cell differentiation. TNF-α was used to activate bone marrow-derived dendritic cells in the presence of 100 or 500 μmol/L acacetin. The expressions of Immature BMDCs were stimulated with TNF-α in the presence of 0, 100, and 500 μg/mL acacetin. F, The levels of cytokine profile, including IL-6, IL-18, IL-10, TGF-β, and MCP-1 were measured by ELISA. G, The purity and phenotypes of BMDCs after stimulation. The experiments were performed at least two times with similar results and data were shown as mean and SEM. *P < 0.05, **P < 0.01, ***P < 0.001 cytokines IL-6 and IL-18, as well as chemokine MCP-1 were significantly decreased in the culture medium (Figure 4F) . The purity and phenotypes of bone marrowderived dendritic cells after acacetin treatment were shown in Figure 4G . Taken together, these data suggested that acacetin could impact the balance of Th17/Treg through influencing the T cell differentiation directly or altering APC function indirectly.
| Acacetin impeded the differentiation of
Th17 cells partly through the inhibition of T cell proliferation and reducing TAZ expression
Numerous studies reported innate immune conversion upon the stimulation of natural compound, but fewer researches described their roles in the alteration of adaptive immunity.
F I G U R E 5
Acacetin regulated the reciprocal differentiation of Th17/Treg partly through the inhibition of T cell proliferation and reducing TAZ expression. Purified CD4+ cells were cultured under Th17-polarized condition in the presence of 0, 100, 200, and 500 μmol/L acacetin. A, The relative cell viability was measured by CCK-8 and quantified. The untreated CD4+ cells were normalized as 1. B, The death cells were stained with PI and analysed by FACS. The experiments were performed at least two times with similar results and data were shown as mean and SEM. C, The stimulation index was measured on the splenic cells from CIA mice upon CII stimulation by CCK8 assay at week 9. The TAZ mRNA level (D) and protein level (E) were measured by real-time PCR or western blotting. F, The image of TAZ by western blotting. The ankle joint were collected for the RNA exaction. The experiments were performed at least two times with similar results and data were shown as mean and SEM. The mRNA levels of TAZ (G), IL-17 (H), and IL-10 (I) in the arthritis tissues were measured by real-time PCR at week 9. n = 6-8 per group. Data were pooled from two individual experiments and shown as box + whiskers and Min to Max (middle bar represented median). *P < 0.05, **P < 0.01, ***P < 0.001
Another interesting question in this study was how acacetin impacted the Th17/Treg balance. The relative cell viability suggested that 200 and 500 μmol/L acacetin could inhibit the cell proliferation upon the stimulation of CD3/CD28 ( Figure 5A ). The PI staining suggested that the addition of acacetin showed little effect on inducing cell death (Figure 5B) , implying less toxicity of acacetin. In addition, the proliferation assay in vivo indicated that the splenic lymphocytes from recipients of acacetin showed lower proliferation ability than that administrated with vehicle upon the stimulation of CII ( Figure 5C ). Recent evidence indicated that TAZ, a transcriptional co-activator, was highly expressed in Th17 cells and attenuated the Treg development. Here, using western blotting and quantitative RT-PCR, we found that TAZ expression in the CD4+ T cells treated with acacetin was significantly reduced under the Th17-polarizatied condition ( Figure 5D -E). Consistent with in vitro results, reducing TAZ expression and IL-17A production were found in the mice administered with 20 mg/ kg acacetin ( Figure 5G-H) . However, the IL-10 was not significantly changed at this time point ( Figure 5I ). These results showed that acacetin might regulate the reciprocal differentiation of Th17/Treg partly through inhibition of cell proliferation and reducing TAZ expression.
| DISCUSSION
In this study, administration of CIA mice with acacetin reduced the CIA incidence, pathological change of ankle joint, and the production of auto-reactive antibodies. The augmented Treg response and dampening Th17 response were related to the effects induced by acacetin treatment. Importantly, acacetin could either impact the differentiation of Th17/Treg cells directly or regulate the function of APCs to alter the balance of Th17/Treg indirectly. Acacetin inhibited the T cell proliferation in vitro and reduced the expression of TAZ, which regulated the generation of Th17 cells. Consistent with this observation, TAZ and IL-17A were reduced in arthritic tissues of the recipients of acacetin.
Although the functions of Th17 cells and Treg cells were opposite, increasing evidence indicated that they were reciprocally interconnected and shared similar developmental pathways. 17, 18 This notion led to a further understanding of autoimmune disorders and would benefit to the new therapy development. Repairing the balance of Th17/Treg response in pathogenesis of RA have been raised as a new target for RA treatment. 19 Epigallocatechin-3-gallate, an active constituent from green tea, was shown to rescue experimental autoimmune encephalomyelitis through the modulation of Th17 and Treg response in lymphoid tissues and central nervous system. 20 In the field of RA, several components, such as tetrandrine, 3-bromopyruvate and cryptotanshinone, showed their abilities to impact the balance of Th17/Treg response and, leading to alleviation of CIA symptoms in mice. 21, 22 Our results revealed a strong ability of acacetin to repress the development of CIA, reduce the production of auto-reactive antibodies, and inhibit the proliferation of pathological T cells. The differentiation of Th17/Treg cells was controlled by adjacent APCs and the tissue microenvironment in lymphoid organs. 17, 23 Therefore, there were at least two ways to influence the process of differentiation: altering APC functions and impeding the intracellular signal transduction. 24 IL-6 produced by DCs or macrophages was one of the most important proinflammatory cytokines that activated the cascade of the kinase JAK and promoted the phosphorylation of STAT3 to evoke the Th17 cell-specific transcriptional factor RORγt. 10 Treatment of anti-IL-6R
antibody triggered Treg but inhibited Th17 cell differentiation, indicating the ability to restore the Th17/Treg balance. 10 When acacetin exposed to immature DCs in the presence of TNF-α, the production of IL-6 was decreased in a dose-dependent manner and in contrast, IL-18 which was critical for the development of Treg cells were increased. Another observation of this study was that under the Th17-polarized condition, the addition of acacetin suppressed the generation of Th17 cells and sustained the expression of Foxp3, implying a direct role in the CD4+ T cell differentiation. Although alteration of phosphorylated-STAT3 expression was most described in this process, recent evidence indicated the critical role of transcriptional coactivator TAZ in the reciprocal regulation of Th17 cells and Treg cells. [25] [26] [27] TAZ attenuated expression of Foxp3 and enhanced the differentiation of Th17 cells. 14 Consistent with our observation, pharmaceutical inhibition of TAZ expression by acacetin significantly prevented the loss of Foxp3 and conflicted to the generation of Th17 cells under the Th17-polarized condition. After acacetin administration, both TAZ and IL-17A mRNA levels were decreased in the arthritic tissue, supporting that acacetin changed the expression of TAZ to control Th17/Treg balance. Yet, the conversion between Th17 cells and Tregs was also found under the arthritic conditions. The most pathological Th17 cells inconceivably originated from antigen-experienced Treg cells. 13, 19 Hence, systemic delivery of acacetin had the chance to inhibit the Treg cells conversion to pathological Th17 cells in RA tissues.
In conclusion, intravenous injection of acacetin repressed the incidence and the severity of CIA. The potential mechanism was partly associated with repair of disordered Th17/Treg balance. Acacetin inhibited the T cell proliferation and the TAZ activity. The Treg population was expanded in vivo after acacetin treatment, opposing pro-inflammatory response mediated by Th17 cells. These
